The pharmaceutical company said late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in the risk of the disease progressing or death.

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...

Two Scottish health boards are trialing a revolutionary artificial intelligence scanning of X-rays to detect signs of lung ...

Smoking affects many parts of the body, especially the lungs and heart. Regular health checkups can help catch problems early ...

qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...

Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced the official launch ...

New robotic technology has arrived at Puyallup’s MultiCare Good Samaritan Hospital – and it creates a world of difference for ...

I sat beside my dad's bed a few days before he passed away and I made him a promise - that I will continue to tell his story ...

A month before her 21st birthday, Amy Clark was given the earth-shattering news that she had stage four lung cancer. It was a ...

John Mauceri had a complicated health history, but his sudden swelling and fatigue left his team of doctors stumped.

A 22 year old woman was left stunned after discovering she had stage-four melanoma, seven tumours in her brain and over 20 in ...